Company: STAA
Filing Date: 2025-10-02
Form Type: DFAN14A
Source: 0001213900-25-095514
Chunk: 9

Company: STAAR SURGICAL CO
Filing Date: 2025-10-02
Form: DFAN14A
Chunk 9
---
 Net Sales ($M) 21% CAGR 10% CAGR … But STAAR’s Near - Term Headwinds Are Abating and Its Prospects Remain Strong 12 After a brief and temporary disruption, management expects STAAR to grow quickly and become more profitable than ever $230 $284 $322 $314 $260 $340 $375 $408 $448 $495 2021 2022 2023 2024 2025P 2026P 2027P 2028P 2029P 2030P $52 $69 $57 $23 $9 $86 $113 $130 $155 $187 2021 2022 2023 2024 2025P 2026P 2027P 2028P 2029P 2030P Temporary Headwinds Temporary Headwinds Source: STAAR Annual Reports on Form 10 - K and proxy statement on Form DEFM14A, filed with the SEC on September 16, 2025 at 61. Return to Growth Return to Growth Adjusted EBITDA ($M)

CONFIDENTIAL © All rights reserved. Two Seas Capital LP INVESTOR PRESENTATION THE WRONG TIME Staar Has Been Facing Temporary Tactical Challenges 02 PART A

Broadwood Partners, L.P. STAAR Has Been Facing Temporary Tactical Challenges 14 ▪ Macroeconomic factors, such as higher interest rates, elevated inflation and tariffs, have weighed on consumer confidence and contributed to a decline in consumer spending ▪ China – a key market for STAAR, which has historically accounted for more than half of the Company’s sales – has faced particularly stiff headwinds because of a housing market downturn Consumer Confidence Has Deteriorated, Especially in China ▪ Refractive procedures – which are cash pay, discretionary, premium purchases – are sensitive to changes in consumer sentiment ▪ Weakened consumer confidence has temporarily negatively impacted demand for refractive surgeries around the world Refractive Procedures Are Down ▪ In February 2025, STAAR disclosed that its inventory levels in China were “elevated” and issued guidance indicating that it was expecting virtually no net sales from China – by far the Company’s largest market – in the first half of 2025 ▪ This revelation, while it reflected a temporary challenge rather than a fundamental impairment to the business, sent STAAR’s stock price tumbling and led to the replacement of the CEO Inventory Levels in China Grew Significantly ▪ Transitory demand